Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m Pharmaceutical Technology
Finance, IT & News
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m Pharmaceutical Technology
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases PR Newswire
NGFA Says No to Proposed Railroad Merger KMAland.com
Samsung Biologics to launch takeover bid for PolyPeptide in September Reuters
ONEOK to Acquire Brazos Midstream's Permian Midland Basin Assets for $4.425 Billion PR Newswire